Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Stephens

Showing results (831-840 of 853) with videos related to

Pageof 86
Sort By:
Neuroimage. Clinical|November 1, 2019
Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathyOrit H Lesman-Segev, Renaud La Joie, Melanie L Stephens, et al.
The Lancet. HIV|June 7, 2020
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trialsChloe Orkin, Edwin DeJesus, Paul E Sax, et al.
Journal of the American Chemical Society|March 22, 2024
Cooperative Effects Drive Water Oxidation Catalysis in Cobalt Electrocatalysts through the Destabilization of IntermediatesBenjamin Moss, Katrine Louise Svane, David Nieto-Castro, et al.
The Journal of Allergy and Clinical Immunology|June 2, 2010
MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity functionRoland Kolbeck, Alexander Kozhich, Masamichi Koike, et al.
ALTEX|January 23, 2013
Evidence-based toxicology for the 21st century: opportunities and challengesMartin L Stephens, Melvin Andersen, Richard A Becker, et al.
The Lancet. Infectious Diseases|November 6, 2015
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority studyAnthony Mills, Jose R Arribas, Jaime Andrade-Villanueva, et al.
Journal of Neurosurgery|November 21, 2015
CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic diseaseBrian L Hoh, Yan Gong, Caitrin W McDonough, et al.
Nature|May 23, 2019
A rigorous electrochemical ammonia synthesis protocol with quantitative isotope measurementsSuzanne Z Andersen, Viktor Čolić, Sungeun Yang, et al.
Acta Neuropathologica|August 23, 2017
Linking tuberous sclerosis complex, excessive mTOR signaling, and age-related neurodegeneration: a new association between TSC1 mutation and frontotemporal dementiaNicholas T Olney, Carolina Alquezar, Eliana Marisa Ramos, et al.
Nature|September 27, 2019
Author Correction: A rigorous electrochemical ammonia synthesis protocol with quantitative isotope measurementsSuzanne Z Andersen, Viktor Čolić, Sungeun Yang, et al.
Pageof 86

Showing results (831-840 of 853) with videos related to

Sort By:
Pageof 86
Neuroimage. Clinical|November 1, 2019
Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathyOrit H Lesman-Segev, Renaud La Joie, Melanie L Stephens, et al.
The Lancet. HIV|June 7, 2020
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trialsChloe Orkin, Edwin DeJesus, Paul E Sax, et al.
Journal of the American Chemical Society|March 22, 2024
Cooperative Effects Drive Water Oxidation Catalysis in Cobalt Electrocatalysts through the Destabilization of IntermediatesBenjamin Moss, Katrine Louise Svane, David Nieto-Castro, et al.
The Journal of Allergy and Clinical Immunology|June 2, 2010
MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity functionRoland Kolbeck, Alexander Kozhich, Masamichi Koike, et al.
ALTEX|January 23, 2013
Evidence-based toxicology for the 21st century: opportunities and challengesMartin L Stephens, Melvin Andersen, Richard A Becker, et al.
The Lancet. Infectious Diseases|November 6, 2015
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority studyAnthony Mills, Jose R Arribas, Jaime Andrade-Villanueva, et al.
Journal of Neurosurgery|November 21, 2015
CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic diseaseBrian L Hoh, Yan Gong, Caitrin W McDonough, et al.
Nature|May 23, 2019
A rigorous electrochemical ammonia synthesis protocol with quantitative isotope measurementsSuzanne Z Andersen, Viktor Čolić, Sungeun Yang, et al.
Acta Neuropathologica|August 23, 2017
Linking tuberous sclerosis complex, excessive mTOR signaling, and age-related neurodegeneration: a new association between TSC1 mutation and frontotemporal dementiaNicholas T Olney, Carolina Alquezar, Eliana Marisa Ramos, et al.
Nature|September 27, 2019
Author Correction: A rigorous electrochemical ammonia synthesis protocol with quantitative isotope measurementsSuzanne Z Andersen, Viktor Čolić, Sungeun Yang, et al.
Pageof 86